✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of fenleuton, a 5-lipoxygenase inhibitor, in ponies

✍ Scribed by K. Marr; K. Marsh; L. Hernandez; F.M. Cunningham; P. Lees

Book ID: 117209856
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 981 KB
Volume: 64
Category: Article
ISSN: 0034-5288
DOI: 10.1016/s0034-5288(98)90005-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacodynamics and Pharmacokinetics of

Pharmacodynamics and Pharmacokinetics of AM103, a Novel Inhibitor of 5-Lipoxygenase-Activating Protein (FLAP)

✍ Bain, G; King, C D; Rewolinski, M; Schaab, K; Santini, A M; Shapiro, D; Moran, M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 300 KB

The role of pharmacokinetics and pharmac

The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy

✍ Mehrotra, N. (author);Gupta, M. (author);Kovar, A. (author);Meibohm, B. (author) 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB

The role of pharmacokinetics and pharmac

The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy

✍ Mehrotra, N. (author);Gupta, M. (author);Kovar, A. (author);Meibohm, B. (author) 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor

✍ Dr. Paul P. Dobesh 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

Dose-proportional pharmacokinetics of a

Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers

✍ Shekman L. Wong; Jeffrey Drajesk; Min S. Chang; Galen Witt; Walid M. Awni 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

, a new potent 5-lipoxygenase inhibitor, is under development for the treatment of asthma. The pharmacokinetics and dose proportionality of ABT-761 after single doses (10 -160 mg) of ABT-761 in 24 healthy male volunteers were investigated in a double-blind, placebo-controlled study. The compound was

Pharmacokinetics of a novel 5-lipoxygena

Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma

✍ S. L. Wong; G. L. Kearns; J. P. Kemp; J. Drajesk; M. Chang; C. S. Locke; L. M. D 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 103 KB